MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Companies: Merger Partners_(M&A)
Yumanity Therapeutics, Inc. (NASDAQ: YMTX)
Organization & Developments: Yumanity
Parents
Yumanity Therapeutics, Inc. (NASDAQ: YMTX)
Children
2021: Yumanity: Speculative Upside Potential In Advance Of Multiple Near-Term Catalysts
2022: Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech
Despite the fact that an estimated 50 million people worldwide suffer from diseases affecting the brain and central nervous system, there are no approved disease-modifying therapies or cures.
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding.
Jumps
Finance & Acquisitions: Yumanity
Key People: Yumanity